Inventions, Startups, & Commercialization

A study published in the July 2024 issue of Rutgers University’s Journal of Studies on Alcohol and Drugs overturned decades of conventional wisdom: No level of alcohol consumption is safe. The news ricocheted across newspapers, blogs and policy papers worldwide. Overnight, drinkers paused, putting down their glasses to ponder the health implications of their habit.

“It is by far our most downloaded article ever,” said Paul Candon, the journal’s editorial director. “The impact and reach in the field are off the charts.”

Rutgers Office for Research is proud to announce the 2025 Rutgers Innovation Awards recipients. In their second year, the Rutgers Innovation Awards (RIA) recognize researchers who have demonstrated excellence by developing a breakthrough idea, process, or technology that has the potential to benefit society and create economic value.

The Office for Research at Rutgers, The State University of New Jersey, has released its Rutgers Research and Innovation Annual Impact Report for Fiscal Year 2025.

Physicist Lucien Dupuy–whose work has captured international recognition--was one of six finalists to receive a Blavatnik Regional Award for Young Scientists, which honors outstanding postdoctoral scientists from research institutions across New York, New Jersey and Connecticut.

Rutgers, The State University of New Jersey, is at the center of the state’s world-renowned research and innovation ecosystem. As the largest public research institution in the Garden State, Rutgers helps to build bridges between companies, higher education research institutions, and government agencies — all in the name of advancing discoveries to address worldwide problems.

NanoNewron, a biotechnology startup developing humanized biologics aiming to cross the blood-brain barrier (BBB) to treat central nervous system (CNS) neurodegenerative diseases, is entering Phase 2 of its TNF-alpha inhibitor program for Alzheimer’s disease. The therapeutic platform is based on research developed at Rutgers, The State University of New Jersey.

Under the guidance of Professor of Chemistry and Center for Computational Biology (CCIB) faculty member Jinglin Fu, Rutgers–Camden students are benefiting from a grant of almost $500,000 from the National Institutes of Health (NIH). The goal of the research is to produce a new nucleic acid nanoparticle-based delivery system for the genome editing of blood stem cells.

The Rutgers Immersive Learning through Science Storytelling Lab, in the School of Environmental and Biological sciences, supports students from a wide variety of majors to partner with Rutgers researchers in the co-creation of compelling video narratives that communicate science as journeys of discovery for peer and public audiences. The Lab’s innovative pedagogical model was recently recognized by the New Jersey State Senate resolution for increasing public trust in science, developing science film leaders, and establishing a model worthy of emulation.